AN OPEN-LABEL STUDY TO EVALUATE THE EFFECT OF EVERY OTHER WEEK PROCRIT� (EPOETIN ALFA) DOSING (40,000-60,000 UNITS) ON MAINTAINING QUALITY OF LIFE AND TARGET HEMOGLOBIN LEVELS IN ANEMIC HIV-INFECTED PATIENTS (CHAMPS II):